Evidence map›Paper›PMID 35343542›Full record

ReviewNatural product reports2022

Chemoenzymatic approaches to plant natural product inspired compounds.

Rebecca Roddan, Eve M Carter, Benjamin Thair, Helen C Hailes

Abstract readReview
In one paragraph

Review in Natural product reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Concise synthesis of (Chemical science · 2023
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rebecca RoddanDepartment of Chemistry, University College London, Christopher Ingold Building, London WC1H 0AJ, UK. h.c.hailes@ucl.ac.uk.ORCID 0000-0002-9406-9011
Eve M CarterDepartment of Chemistry, University College London, Christopher Ingold Building, London WC1H 0AJ, UK. h.c.hailes@ucl.ac.uk.ORCID 0000-0002-0896-6884
Benjamin ThairDepartment of Chemistry, University College London, Christopher Ingold Building, London WC1H 0AJ, UK. h.c.hailes@ucl.ac.uk.
Helen C HailesDepartment of Chemistry, University College London, Christopher Ingold Building, London WC1H 0AJ, UK. h.c.hailes@ucl.ac.uk.ORCID 0000-0001-5574-4742

Funding

Wellcome TrustWellcome Trust 219857/Z/19/Z
6 · The paper itself

Abstract

Covering: 2003 up to the end of 2021Complex molecules produced by plants have provided us with a range of medicines, flavour and fragrance compounds and pesticides. However, there are challenges associated with accessing these in an economically viable manner, including low natural abundance and the requirement for complex multi-step synthetic strategies. Chemoenzymatic approaches provide a valuable alternative strategy by combining traditional synthetic methods with biocatalysis. This review highlights recent chemoenzymatic syntheses towards plant natural products and analogues, focusing on the advantages of incorporating biocatalysts into a synthetic strategy.

Indexed as

Biological ProductsBiocatalysisBiological Products

Identifiers

PMID35343542
PMCPMC9298680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.